208 related articles for article (PubMed ID: 12828817)
1. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.
Buse JB; Freeman JL; Edelman SV; Jovanovic L; McGill JB
Diabetes Technol Ther; 2003; 5(3):355-63. PubMed ID: 12828817
[TBL] [Abstract][Full Text] [Related]
2. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
Dungan KM
Expert Rev Mol Diagn; 2008 Jan; 8(1):9-19. PubMed ID: 18088226
[TBL] [Abstract][Full Text] [Related]
3. Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control.
Yamanouchi T; Akanuma Y
Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S261-8. PubMed ID: 7859616
[TBL] [Abstract][Full Text] [Related]
4. 1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events.
Migała M; Chałubińska-Fendler J; Zielińska M
Rev Diabet Stud; 2022 Jun; 18(2):68-75. PubMed ID: 35831937
[TBL] [Abstract][Full Text] [Related]
5. Clinical and forensic examinations of glycemic marker 1,5-anhydroglucitol by means of high performance liquid chromatography tandem mass spectrometry.
Hess C; Stratmann B; Quester W; Madea B; Musshoff F; Tschoepe D
Forensic Sci Int; 2012 Oct; 222(1-3):132-6. PubMed ID: 22749674
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.
Kim MJ; Jung HS; Hwang-Bo Y; Cho SW; Jang HC; Kim SY; Park KS
Acta Diabetol; 2013 Aug; 50(4):505-10. PubMed ID: 21688018
[TBL] [Abstract][Full Text] [Related]
7. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
Dungan KM; Buse JB; Largay J; Kelly MM; Button EA; Kato S; Wittlin S
Diabetes Care; 2006 Jun; 29(6):1214-9. PubMed ID: 16731998
[TBL] [Abstract][Full Text] [Related]
8. Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0.
Ouchi S; Shimada K; Miyazaki T; Takahashi S; Sugita Y; Shimizu M; Murata A; Kadoguchi T; Kato T; Aikawa T; Suda S; Sai E; Hiki M; Iwata H; Kasai T; Miyauchi K; Daida H
Cardiovasc Diabetol; 2017 Nov; 16(1):151. PubMed ID: 29157245
[TBL] [Abstract][Full Text] [Related]
9. The use of 1.5-anhydroglucitol for monitoring glycemic control in islet transplant recipients.
Peixoto EM; Bozkurt NC; Messinger S; García MI; Lauriola V; Corrales A; Herrada E; Ricordi C; Alejandro R
Cell Transplant; 2014; 23(10):1213-9. PubMed ID: 23803279
[TBL] [Abstract][Full Text] [Related]
10. A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control.
Stickle D; Turk J
Am J Physiol; 1997 Oct; 273(4):E821-30. PubMed ID: 9357814
[TBL] [Abstract][Full Text] [Related]
11. 1,5-anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes.
Seok H; Huh JH; Kim HM; Lee BW; Kang ES; Lee HC; Cha BS
Diabetes Metab J; 2015 Apr; 39(2):164-70. PubMed ID: 25922811
[TBL] [Abstract][Full Text] [Related]
12. 1,5-anhydroglucitol monitoring in diabetes: a mass balance perspective.
Nerby CL; Stickle DF
Clin Biochem; 2009 Feb; 42(3):158-67. PubMed ID: 18804100
[TBL] [Abstract][Full Text] [Related]
13. Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus.
Nguyen TM; Rodriguez LM; Mason KJ; Heptulla RA
Pediatr Diabetes; 2007 Aug; 8(4):214-9. PubMed ID: 17659063
[TBL] [Abstract][Full Text] [Related]
14. Predicting long-term glycemic control of post-educational type II diabetic patients by evaluating serum 1,5-anhydroglucitol levels.
Sone H; Okuda Y; Yamaoka T; Kawakami Y; Odawara M; Matsushima T; Kawai K; Yamashita K
Diabetes Res Clin Pract; 1996 Oct; 34(2):83-8. PubMed ID: 9031810
[TBL] [Abstract][Full Text] [Related]
15. Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
Yamanouchi T; Minoda S; Yabuuchi M; Akanuma Y; Akanuma H; Miyashita H; Akaoka I
Diabetes; 1989 Jun; 38(6):723-9. PubMed ID: 2656341
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer.
Nowatzke W; Sarno MJ; Birch NC; Stickle DF; Eden T; Cole TG
Clin Chim Acta; 2004 Dec; 350(1-2):201-9. PubMed ID: 15530479
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM.
Tsukui S; Fukumura Y; Kobayashi I
Diabetes Care; 1996 Sep; 19(9):940-4. PubMed ID: 8875086
[TBL] [Abstract][Full Text] [Related]
18. Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.
Su H; Ma X; Yin J; Wang Y; He X; Bao Y; Zhou J; Jia W
Acta Diabetol; 2017 May; 54(5):463-470. PubMed ID: 28210869
[TBL] [Abstract][Full Text] [Related]
19. Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol.
Yamanouchi T; Moromizato H; Shinohara T; Minoda S; Miyashita H; Akaoka I
Metabolism; 1992 Aug; 41(8):862-7. PubMed ID: 1640864
[TBL] [Abstract][Full Text] [Related]
20. A new method of quantitating serum and urinary levels of 1,5-anhydroglucitol in insulin-dependent diabetes mellitus.
Namba N; Watanabe F; Tokuda M; Mino M; Furuya E
Diabetes Res Clin Pract; 1994 May; 24(1):55-61. PubMed ID: 7924887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
